POPULARITY
Categories
Angela Madden, Executive director of Michigan Association of Ambulance Services (MAAS) and Michigan Association of Emergency Medical Technicians (MAEMT). Michigan EMS leaders celebrate first responders, call for state reimbursement of unpaid emergency services during EMS Recognition Week
Courtney Turich shares the journey of Cooler Heads, the startup behind a scalp cooling device that helps chemo patients keep their hair and dignity. From early challenges to reaching over 100 infusion centers, she reveals how awareness, advocacy, and social media-fueled their growth. We explore the emotional impact of scalp cooling, the barriers to oncologist adoption, and the company's commitment to patient education. Courtney also offers career advice for breaking into medical sales, thriving in startups, and leading with purpose. This is a must-listen for anyone who wants to build a mission-driven career, create a real impact in healthcare, or understand what it takes to grow a successful medical startup. Connect with Courtney: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How » Want to connect with past guests and access exclusive Q&As? Join our EYS Skool Community today!
When patients understand their inherited risk for cancer, they're empowered to take action—often before cancer has a chance to take hold.In this second episode of our Bringing Precision Medicine to Every Patient series, host Karan Cushman is joined by two trusted experts, Ellen Matloff and Dr. Angella Charnot-Katsikas. Together, they provide clear, practical guidance on how patients and clinicians can identify inherited cancer risk early—and take steps to address it.Whether you're a patient wondering where to begin, or a provider navigating limited time and resources, this episode delivers clear takeaways to help you move from uncertainty to informed action.It's a timely reminder that precision medicine doesn't begin with treatment—it begins with knowledge. And with the right tools and support, patients can take control of their health and rewrite the story for generations to come.Ellen Matloff is a nationally recognized genetic counselor, founder and CEO of My Gene Counsel, and a leading voice in digital health and patient-centered genomics. She founded and led the Yale Cancer Genetic Counseling Program and was a plaintiff in the landmark Supreme Court case that overturned gene patenting.Dr. Angella Charnot-Katsikas is Chief Medical Officer at Palmetto GBA and a molecular diagnostics expert who helps guide coverage decisions through her work in precision medicine policy.They share compelling stories that bring the science to life. Ellen reflects on one of her first BRCA1-positive patients—a healthy young mother who chose preventive surgery based on a powerful family history of cancer and a determination to break the cycle. Dr. Katsikas offers her own experience as both a pre-vivor and survivor, whose early diagnosis was only possible because of proactive testing and screening guided by her family history.The episode also explains why many patients still miss these opportunities—due to limited awareness, inconsistent risk assessments, and systemic barriers in access. The guests highlight the limitations of consumer tests like 23andMe and the critical role of genetic counselors in interpreting results and guiding decisions.They offer actionable strategies for integrating family history collection and risk assessment into routine care, including the use of digital tools in busy or resource-limited settings. Reimbursement challenges are discussed, alongside encouraging progress toward making precision medicine standard of care.Special thanks to our good friend Dr. Kashyap Patel and the No One Left Alone initiative forcollaborating with us on this series. Our goal with Bringing Precision Medicine to Everyone is to equip patients, caregivers and care teams with the knowledge and tools needed to deliver the best of modern cancer care–no matter where a patient lives.
In this episode of the Becker's Healthcare Podcast, Erika Spicer Mason speaks with Brian Workinger and Lauree Handlon of The Craneware Group about how AI and data-driven insights are helping providers navigate increasingly complex payer contracting and reimbursement environments. The conversation covers predictive modeling, payer transparency, and preparing for shifts in Medicare Advantage participation, all within the broader context of value-based care. Tune in to hear how hospitals can leverage advanced analytics to drive smarter financial strategies and improve long-term sustainability.This episode is sponsored by Craneware.
https://nebraskalegislature.gov/bills/view_bill.php?DocumentID=59590Introduced by Senator Jacobsen, January 22ndBanking, Commerce and Insurance CommitteeApr 03, 2025, Passed on Final Reading with Emergency Clause 47-0-2, Excused, not voting are the only “2” votesApproved by Governor on April 7, 2025 We rely on your donations to keep producing this podcast content and to support physician advocacy in Nebraska. If you would like to support Nebraska Alliance for Physician Advocacy, a 501(c)(3) organization in Nebraska please click to DONATE NOW. If you have questions or answers, please email us at contact@nebraskaallianceforphysicianadvocacy.org Please check out our website at: Nebraska Alliance for Physician Advocacy
Send us a textIn this episode of the Advancing Surgical Care Podcast, ASCA Chief Executive Officer Bill Prentice talks with Robert Saltaformaggio, senior counsel at Liles Parker, a Washington, DC-based law firm that focuses on regulatory healthcare compliance and reimbursement issues. Saltaformaggio is also a certified professional coder who assists ASCs and other healthcare providers with Medicare and Medicaid payer coverage and payment requirements, as well as claims disputes with major payers such as the various Blue Cross Blue Shield entities and UnitedHealthcare. During their discussion, Prentice and Saltaformaggio talk about the current regulatory landscape, the role of AI, the importance of conducting self-audits and more.
May 16, 2025 Scott and Mark switch roles to introduce the new PRS Coding and Reimbursement Hub, featuring Jelmyto as an example. The Hub helps practices simplify workflow, coding, and reimbursement processes. Scott explains how the Hub provides clear, trusted guidance, enabling urology practices to streamline reimbursement, reduce confusion, and accelerate patient access.PRS Coding and Reimbursement HubAccess the HubJelmyto Coding and Reimbursement PageUpper Track Urothelial Cancer (UTUC) Coding and Reimbursement PageFree Kidney Stone Coding CalculatorDownload NowPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.https://www.prsnetwork.com/joinuptp Click Here to Start Your Free Trial of AUACodingToday.com The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Dr. Arun Menawat, Chairman and CEO of Profound Medical. Profound is commercializing the TULSA-PRO system, an alternative approach to prostate cancer treatment that uses MRI-guided thermal ultrasound to target and eliminate cancerous tissue without surgical incisions. Before joining Profound in 2016, Arun served as the Chairman and CEO of Novadaq Technologies for 13 years, guiding the company from a startup to one of the fastest-growing, NASDAQ-listed medical technology businesses with a market cap exceeding one billion USD. Earlier in his career, Arun served as President of Cedara Software, a company that developed the industry's first medical imaging software platform. Today, it's part of IBM's Watson Health.In this interview, Arun shares insights on building credibility with physicians, the strategic approach to clinical trials that led to their recent Medicare reimbursement coverage, and his vision for transforming the future of surgery beyond prostate cancer.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Arun Menawat.
Radiology reports are rich in clinical detail, yet ICD-10 codes often fail to fully capture the complexity and specificity of imaging findings.That is why the producers of Talk Ten Tuesdays and ICD10monitor have invited Laura Manser to explore the most common disconnects between radiology documentation and ICD-10 coding – especially in areas like incidental findings, laterality, and linking imaging results to medical necessity.During the next edition of the weekly broadcast, Manser is also expected to highlight common errors, such as coding suggestive findings as definitive diagnoses, and provide practical guidance on bridging the gap between documentation and compliance.Also part of the live broadcast will be these instantly recognizable panelists, who will report more news during their segments:• Social Determinants of Health: Tiffany Ferguson, CEO for Phoenix Medical Management, Inc., will report on the news that is happening at the intersection of medical record auditing and the SDoH.• The Coding Report: Christine Geiger, Assistant Vice President of Acute and Post-Acute Coding Services for First Class Solutions, will report on the latest coding news.• News Desk: Timothy Powell, ICD10monitor national correspondent, will anchor the Talk Ten Tuesdays News Desk.• MyTalk: Angela Comfort, veteran healthcare subject-matter expert, will co-host the long-running and popular weekly Internet broadcast. Comfort is the Assistant Vice President of Revenue Integrity for Montefiore Health.
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Claire Dixon, CEO of Neuraura.Neuraura is developing LoOop, an over-the-counter wearable that targets PCOS through low-frequency electrical stimulation.Claire brings over 25 years of international leadership experience to her role as co-founder and CEO of Neuraura. With a master's degree in engineering from Cambridge and an MBA from Harvard, she spent 15 years as a strategic consultant to capital-intensive businesses before transitioning to entrepreneurship. She was recently named among the “Top 200 Trailblazing Leaders in Women's Health and femtech” by Women of Wearables.In this interview, Claire shares insights on navigating regulatory pathways, designing for real user needs, and building strategic partnerships to bring innovative women's health solutions to market through a direct-to-consumer approach.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Claire Dixon.
Among plans to cut waiting lists is a reimbursement scheme, allowing patients to pay up front for a procedure and then receive the money back - what if you don't have the cash? Rick spoke to Alliance's Danny Donnelly Hosted on Acast. See acast.com/privacy for more information.
Angela Holland: Preferred Dental Solution Join Elevated GP: www.theelevatedgp.com Free Class II Masterclass - Click Here to Join Follow @dental_digest_podcast Instagram Follow @dr.melissa_seibert on Instagram Angela Holland is a seasoned dental insurance expert and the founder of Preferred Dental Solutions, a firm dedicated to helping dental practices nationwide maximize their insurance reimbursements. With over a decade of experience in the dental industry, Angela has become a trusted advisor for practices aiming to enhance their financial performance through strategic insurance management. Angela began her career in dental consulting in 2013, quickly recognizing the challenges practices faced with insurance billing and revenue cycle management. In 2018, she founded Preferred Dental Services, focusing exclusively on remote insurance revenue cycle management. Under her leadership, the company grew rapidly, culminating in its acquisition by a NASDAQ-traded corporation in 2023. Following this success, Angela launched Preferred Dental Solutions, offering specialized services in insurance credentialing and PPO fee negotiations. Her team provides live progress updates and guarantees increased insurance revenue, reflecting her commitment to transparency and results. Angela's expertise has led to significant financial improvements for her clients, with some practices reporting revenue increases of up to 46% with major insurers like Cigna and MetLife. Her dedication to empowering dentists and her deep understanding of the insurance landscape make her a valuable partner for practices seeking growth and efficiency. For more information or to connect with Angela, visit Preferred Dental Solutions.
Officials say a federal program to increase Medicare and Medicaid reimbursements to rural hospitals could be a lifeline for their community.Then, aspiring Mississippi entrepreneurs seek to win a $15 thousand dollar prize for innovative tech ideas.Plus, we speak with a member of the Tougaloo 9, whose read-in protest in the 1960's helped lead the charge to desegregate libraries. Hosted on Acast. See acast.com/privacy for more information.
May 2, 2025 In this episode, Scott, Mark, and Ray share highlights from the AUA 2025 Annual Meeting in Las Vegas, discussing exciting new technologies, reimbursement challenges, key conversations, and updates from the urology community.Free Kidney Stone Coding CalculatorDownload NowPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.https://www.prsnetwork.com/joinuptp Click Here to Start Your Free Trial of AUACodingToday.com The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/
Tune in for Episode 52 as Dave hosts two guests to the show—Missie Scheffman and Nick Rella.Missie Scheffman, Director of Reimbursement at Astellas Pharma, is a nationally recognized speaker, conference chair, and proud ambassador club member of Win the 16.Joining her is Nick Rella, a Healthcare Business Leader at Bausch + Lomb Pharma, an eleven-time nationally recognized leader with nearly three decades of experience in team leadership. A mastermind at building high-performance teams, Nick is also a “Win the 16” Advisor.Together, they dive into topics such as the importance of investing in yourself, fostering a growth mindset, mastering the balance between likability and intelligence, embracing change agility, and more. Don't miss this insightful and inspiring conversation!
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Vicky Demas, CEO of identifeye HEALTH (formerly Tesseract Health), who's leading the company's efforts to democratize access to retinal imaging. Using advanced algorithms and automated systems, identifeye's technology captures and analyzes retinal images to detect early signs of disease.Before joining identifeye HEALTH, Vicky led new product development at GRAIL, supporting the creation of the company's multi-cancer early detection test (Galleri). She was also a founding member of Google Life Sciences (later Verily) within Google [x], where she led teams focused on diagnostics, medical devices, and translational laboratory science. An engineer and scientist, Vicky holds over 20 patents and has authored numerous scientific publications across multiple disciplines.In this interview, Vicky challenges founders to consider: Are you building a diagnostic solution that can scale globally or a product limited to specialized healthcare settings? She also discusses why understanding real-world implementation challenges early can prevent costly missteps later.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Vicky Demas.
In this episode of the Global Medical Device Podcast, Etienne Nichols speaks with renowned regulatory and reimbursement expert Karandeep Singh Badwal to uncover the complexities of medical device reimbursement across the US, EU, and Asian markets. From the influence of governmental systems to the nuances of coding, coverage, and payments, Karandeep shares real-world insights for MedTech companies developing their global market strategies. Learn why early planning for reimbursement is just as crucial as regulatory approval, and how future-proofing your strategy against political and economic changes can safeguard your device's success.Key Timestamps:00:00 – Intro and Sponsor Message (Greenlight Guru Quality)02:30 – Why Reimbursement Must Be Considered Early07:15 – US Reimbursement System: Medicare, Medicaid, and Private Insurers13:10 – EU Reimbursement: Challenges with Fragmented National Systems17:45 – Asian Market Differences: Japan, China, and South Korea23:20 – The Importance of a Reimbursement Expert28:05 – Navigating Political Changes in Global MedTech Markets33:30 – Special Challenges for AI and Software as a Medical Device40:00 – Direct-to-Consumer vs. Prescription Strategies46:20 – Integrating Real-World Evidence and Post-Market Surveillance52:00 – How Management Reviews Can Align Business and Quality Goals01:03:10 – Pros and Cons: US vs. EU Reimbursement Models01:18:20 – Final Takeaways and Closing ThoughtsStandout Quotes:"Reimbursement isn't just the final step after regulatory approval — it is a core business strategy."Why it matters: Many companies fail by not building reimbursement into their earliest development and design decisions."You can have the most innovative medical device in the world, but without a reimbursement pathway, you won't have a viable business."Why it matters: Innovation alone isn't enough; financial strategy is crucial to survival and growth.Top Takeaways:Start with reimbursement in mind: Align your product claims, indications, and market strategies with potential reimbursement pathways early.Tailor by region: US, EU, and Asian markets all have distinct reimbursement landscapes — success in one doesn't guarantee success in another.Hire jurisdiction-specific experts: Use consultants experienced in your target markets to avoid costly mistakes.Leverage post-market surveillance: Integrate real-world evidence gathering into your QMS and management reviews to support reimbursement claims.Build strategic flexibility: Political and regulatory landscapes shift — maintain backup jurisdictions and alternative market strategies.References:Etienne Nichols on LinkedInGreenlight Guru Quality Management SystemMedtech Podcast hosted by Karandeep Singh BadwalMedTech 101 Section:What is "Reimbursement" in MedTech?Reimbursement refers to how a company gets paid for a medical device after it's cleared for use. This usually involves navigating government programs (like Medicare) or private insurance, and it determines how easily hospitals, clinics, or individuals can buy and use a product.Simple Analogy: Think of it like getting a movie produced: regulatory clearance is getting your movie rated, but reimbursement is making sure theaters agree to pay you to...
In this episode, Victoria Hernandez provides us with a glimpse into BESLER Academy Webinar, Understanding New Technology Add-on Payment (NTAP) - Its Role & Significance in Hospital Reimbursement, presented live on April 30, 1 PM ET.
The fiscal year (FY) 2026 Inpatient Prospective Payment System (IPPS) proposed rule introduces significant reforms to hospital reimbursement, risk adjustment, and performance measurement.Key changes include the Centers for Medicare & Medicaid Services (CMS) transition to HCC Version 28, the use of the Community Deprivation Index (CDI) for socioeconomic risk adjustment and expanded inclusion of Medicare Advantage data in quality metrics.Launching in 2026, the proposed rule mandates episode-based payments with enhanced pricing accuracy. Hospitals must adapt by updating financial models, realigning quality strategies, and fostering cross-departmental collaboration. These changes emphasize equity, accountability, and transparency, all of which is designed to help in the positioning hospitals to lead in a value-driven healthcare environment.Strategic readiness is critical to thrive under IPPS 2026. Reporting this story, during the next live edition of Monitor Mondays, will be the broadcast's special guest Penny Jefferson.The long-running broadcast will also include these instantly recognizable features:• Monday Rounds: Ronald Hirsch, MD, vice president of R1 RCM, will be making his Monday Rounds.• Risky Business: Healthcare attorney David Glaser, shareholder in the law offices of Fredrikson & Byron, will join the broadcast with his trademark segment.• The RAC Report: Healthcare attorney Knicole Emanuel, partner at the law firm of Nelson Mullins, will report the latest news about auditors.• Legislative Update: Folana Houston, senior government affairs liaison for Zelis, will report on congressional action taking place in Washington, D.C.• News Update: Dr. Drew Update will have an update to his recent reporting on transgender treatment practices.
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Randy Pritchard and Erica Rogers, leaders of Axena Health. Axena is transforming pelvic floor therapy with Leva, a device bringing clinically-proven, supervised pelvic floor muscle training into women's homes. Randy, CEO of Axena, brings nearly 25 years of healthcare experience to the company, most recently as CEO of Pillar Biosciences and previously holding leadership positions at Roche Diagnostics, where he spent 18 years developing commercial expertise. Erica, who sits on Axena's Board of Directors, spent a decade as President and CEO of Silk Road Medical, leading the company from early clinical trials through IPO and eventual acquisition by Boston Scientific. A returning guest to the podcast after nearly half a decade, Erica previously held roles at Medicine360, co-founded two other medical device companies, and spent over 12 years at Boston Scientific prior to her role at Silk Road.In this interview, they share essential medtech commercialization insights: identify your specific patient segment, build continuous clinical evidence, and communicate consistently with investors. Their experience offers invaluable lessons for medical device entrepreneurs navigating today's complex healthcare landscape.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Randy Pritchard and Erica Rogers.
Sandy DiVarco, Partner, McDermott Will & Emery LLP, and Dan Hettich, Partner, King & Spalding LLP, discuss issues related to Medicare and the practice of law in this area. They cover Medicare reimbursement for hospitals, different licensure requirements, EMTALA, provider-based status and site-neutral care, the Advocate Christ case, and what it's like as an attorney to practice in a niche area like Medicare law. Sandy and Dan, among others, were authors of AHLA's Fundamentals of Health Law, Eighth Edition.Watch the conversation here.AHLA's Health Law Daily Podcast Is Here! AHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Premium members. Get all your health law news from the major media outlets on this new podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.
There's a notable gender gap with glaring disparity in reimbursement when it comes to urologic care for women and gynecologic care. Why are urologists being reimbursed at higher rates than urogynecologists for the same procedures? This week's guest has observed and analyzed such disparities throughout her medical career - and now has the research to back it up. Dr. Jocelyn Fitzgerald is a UroGynecologist and Pelvic Reconstructive Surgeon at University of Pittsburgh Medical Center (UPMC). Hear how RVUs (Relative Value Units) work, the significant reimbursement gaps that exist, and the prevalence of burnout in OB/GYN professionals. Contemplate the calls to action proposed by Dr. Fitzgerald. Dive into some clinical juggernauts in the space including incontinence and urinary tract infections (UTIs). Tune in to this episode to squash the reimbursement gap! Learn more: Dr. Jocelyn Fitzgerald at UPMC Dr. Jocelyn Fitzgerald LinkedIn Today's Hot Flash and other stats from: Journal of Women's Health
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Ryan Rhodes, CEO of EDAP TMS. EDAP is changing prostate cancer treatment through Focal One, a robotic high-intensity focused ultrasound (HIFU) system that doesn't require the use of surgery or radiation. Ryan has over 30 years of experience in market development, with two decades focused on medical robotics. Before EDAP, Ryan was CEO of Restoration Robotics, where he guided the company to a successful merger with Venus Concept. He spent 13+ years at Intuitive Surgical, establishing the global Urology franchise, which became the company's entry point for broader adoption of the da Vinci system. He also spent 11 years at Ethicon (J&J) in sales, marketing, and market development.In this interview, Ryan challenges founders to ask: Are you creating a scalable medtech solution or a product with limited growth potential? He unpacks why standardization and scalability are critical for adoption, how clinical data fuels credibility and reimbursement, and why early adopters take the biggest risks — but also reap the biggest rewards.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Ryan Rhodes.
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Kirk Huntsman, CEO of Vivos, a company commercializing a non-invasive, FDA-cleared oral appliance designed to treat obstructive sleep apnea (OSA). Kirk is a seasoned healthcare entrepreneur with a track record for scaling and exiting successful businesses. He founded Dental One, growing it into one of the largest dental service organizations (DSO) in the U.S., with over 165 practices across 15 states. After selling the company to MSD Capital, he led ReachOut Healthcare America, a Morgan Stanley Private Equity portfolio company. He later built and exited Xenith Practices, another DSO, and founded Ortho Ventures, focusing on pediatric oral appliances. Now as CEO of Vivos, Kirk and his team are developing and commercializing proprietary treatments for sleep-related breathing disorders, offering patients an FDA-cleared alternative to CPAP therapy.In this interview, Kirk talks about his go-to-market strategy, the importance of credibility markers, the complexity of industry partnerships, and the challenges he faced pursuing an IPO.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Kirk Huntsman.
In this episode, Rani Khetarpal, MBA, and Jeanne Silva, MSN, RN-BC, CN-BN, CMSRN, discuss the importance of reimbursement in navigation and implementation of PIN codes.Thank you to our sponsor, Lilly, for providing funding for this podcast.
In this episode, host Mitch Robbins interviews Mickey Brown, Vice President of Access and Reimbursement at Cerapedics, discussing his 30+ year career journey and insights on healthcare market access.Key Highlights:Mickey shares his transition from 15 years on the payer side (Blue Cross, United Healthcare) to manufacturer roles at Medtronic, Cochlear, and now CerapedicsLearn how stepping outside his comfort zone at critical moments propelled his career forwardDiscover the biggest challenges facing market access professionals in 2025Understand common reimbursement strategy mistakes companies make and how to avoid themPractical Takeaways:Why waiting too long to develop reimbursement strategy hurts product launchesThe key differences between director and VP-level thinkingWhat makes an outstanding market access professionalHow to effectively engage with increasingly inaccessible payersWhether you're in medical device sales, reimbursement, or aspiring to leadership roles in healthcare, this conversation offers valuable insights from both sides of the healthcare ecosystem.
In today's episode of Industry Matters Boone Lockard, VP of Clinical Services; Ronda Buhrmester, Sr Director Payer Relations & Reimbursements; Zach Gantt, CEO, Encore Healthcare; and Ray Gregg, VP of Sales and Business Development, Encore Healthcare; dive into the latest updates on the National Coverage Determination (NCD) for ventilators, focusing on the new policy changes and their implications for COPD patients. CMS has 60 days to review comments which means the final comments should be released by June 9th.Submit Comments Here:https://www.cms.gov/medicare-coverage-database/view/ncacal-tracking-sheet.aspx?ncaid=315
In this episode, BESLER leaders give us with a glimpse into BESLER's next free webinar, Exploring IME & GME - Hospital Reimbursement & Revenue Integrity Perspectives, live on Wed., Apr. 2, at 1 PM ET.
Toni explains Medicare form CMS 1490S and how to be reimbursed by Medicare for a covered medical expense. Want more information? Take advantage of Toni's brand new video series now a available at https://tonisays.com Remember - with Medicare it's what you don't know that will hurt you! There's so much good information in this podcast, please be sure to share this podcast with your friends! Recognized by feedspot.com as one of the best Medicare Podcasts in the nation! Write Toni - info@tonisays.com. Toni's book is available at www.seniorresource.com and https://tonisays.com You can call Toni at 832-519-8664 Toni welcomes all Medicare questions. Toni now offers informative Medicare Webinars for all of your Medicare needs at https://tonisays.com You can find Medicare Moments wherever you find your favorite podcasts, such as: Apple: https://apple.co/44MoguG Spotify: https://open.spotify.com/show/7c82BS4hb145GiVYfnIRsoAmazon Music: https://music.amazon.com/podcasts/884c1f46-9905-4b29-a97a-1a164c97546b/medicare-moments?refMarker=null You can find Medicare Moments at: https://podcasts.seniorresource.com/medicare-moments/ Toni's new book: Maze of Medicare is now available at www.tonisays.com Combining Scripture with Medicare, it is the only book of its kind. Toni's columns appear weekly in about 100 newspapers across America. If you would like Toni's column to appear in your local paper, or if you would like Toni to speak at an event - contact Toni King at 832-519-8664 Thank you for listening and be sure to tell your friends about Medicare Moments! Blessings! Toni KingSee omnystudio.com/listener for privacy information.
Federal Workers Compensation Coffee Break Podcast is an educational and informative training on how to navigate the DOL -OWCP claims filing process for all types of injured US government and federal workers. The podcast is free and is educational. If you need help with anything related to a federal workers compensation claim...help is just a cup of coffee away.Step-by-Step Tutorial: How to Fill Out and Submit OWCP Form 957 for Travel Reimbursement If you're a federal employee or a worker covered under programs like the Federal Employees' Compensation Act (FECA), Black Lung Benefits Act, or the Energy Employees Occupational Illness Compensation Program Act (EEOICPA), you may be eligible to get reimbursed for travel expenses related to medical treatment for a work-related injury or illness. The key to unlocking this benefit is the OWCP-957 form, also known as the Medical Travel Refund Request. In this step-by-step tutorial, I'll walk you through how to fill out and submit this form accurately to ensure you get reimbursed without unnecessary delays. Step 1: Understand When to Use the OWCP-957Before you start, confirm that your travel qualifies for reimbursement. The OWCP-957 is for travel expenses tied to medical care for an accepted work-related condition—think doctor visits, pharmacy trips, or approved treatments. You can claim up to three trips per form, and all requests must be submitted within one year of the expense. If your travel exceeds 200 miles round-trip, you'll need pre-approval from your OWCP Medical Benefits Examiner, so keep that in mind. There are two different 957 forms for the process of filing for medical travel reimbursement.OWCP-957A - Medical Travel Refund Request – MileageOWCP-957B - Medical Travel Refund Request – ExpensesFor more information click on the show transcript:Dr. Taylor's contact information is: fedcompconsultants@protonmail.com If you need a medical provider or assistance with an OWCP / DOL claim in Tampa, Pensacola Florida or Mobile Alabama you can make an appointment to see Dr. Taylor, or Dr. Sullivan at the clinic at FWC Medical Centers. To make a consultation with Dr. Taylor call the clinic at 813-215-4356 or go to our website at https://mrtherapycenter.com/or https://fedcompconsultants.com/For responses email Dr. Taylor at fedcompconsultants@protonmail.comFEEDSPOT TOP 10 National Workers Compensation Podcast: https://podcast.feedspot.com/workers_compensation_podcasts/?feedid=5557942&_src=f2_featured_email
The reality of running a private practice in 2025 is tough—Medicare cuts, rising payroll costs, and staff turnover are making it harder than ever to stay profitable. In this episode, Brian Gallagher breaks down exactly what PT owners must do to survive and thrive in today's economy. From renegotiating insurance contracts to restructuring your team for maximum efficiency, this is a coaching session you don't want to miss. Key Takeaways: ✅ Why fighting insurance reimbursement cuts requires a strategic approach (not just form letters). ✅ The #1 reason PT payroll is skyrocketing—and how to fix it. ✅ The staffing strategy that reduces burnout, improves efficiency, and cuts costs. ✅ The simple marketing shift that can generate a steady stream of new patients. ✅ Why running a monthly P&L is critical to keeping your practice financially healthy. Book a Disacover Call Today!: Click Here
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Caitlin Morse, CEO and co-founder of BrainSpace, who has a decade of experience spanning medtech consulting, product development, and strategic advising. BrainSpace is developing an innovative precision drainage system with continuous ICP monitoring designed to automate cerebrospinal fluid management for patients recovering from strokes, traumatic brain injuries, and neurosurgery. In this interview, Caitlin shares her advice on assessing the viability of a medtech idea, tells the story of how her prototype won over stakeholders, and discusses navigating the development phase while balancing clinical and regulatory demands.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Caitlin Morse.
Dr. Adam Pitts discusses the relationship between coding and reimbursement. Sharing his own experience participating in AAOMS coding courses with his staff, Dr. Pitts explains why he believes all OMSs need to learn how to code properly to maximize reimbursements and remain in compliance with federal regulations and managed care contracts.
Welcome to Season 2 of the Orthobullets Podcast.Today's show is Podiums, where we feature expert speakers from live medical events. Today's episode will feature Dr. Paul Slosar and is titled Changes in Reimbursement Models - Risk Sharing Models.Follow Orthobullets on Social Media:FacebookInstagram TwitterLinkedInYouTube
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we had an insightful discussion with Drs. Asha Parekh and Adam Power, co-founders of Front Line Medical Technologies. The company's COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System) is a compact, minimally invasive device, designed for temporary aortic occlusion in trauma situations. Asha has a PhD in Biomedical Engineering from Western University, and combines technical expertise with entrepreneurial leadership. Adam is an academic and practicing vascular surgeon at Western University, with extensive training from institutions including Dalhousie, McMaster, and Mayo Clinic.In this interview, they discuss how their clinical-engineer partnership accelerated development, their approach to clinical studies for regulatory clearance across multiple geographies, and their strategic decision to avoid VC funding during early development—and how that decision paid off.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Asha Parekh and Adam Power.
Are Dental Billing and Medical Billing the Same Thing?Terry Fletcher discusses the similarities, differences, and where crossover between dental and medical billing.Tune in for advice that can assist clients on both sides to be accurate in their coding and billing processes.
In this episode of Voices of Otolaryngology, Rahul K. Shah, MD, MBA, AAO-HNS/F Executive Vice President and CEO, visits Annette M. Pham, MD, Chair of the AAO-HNS Otolaryngology Private Practice Section, at her practice, The Centers for Advanced ENT Care, in Rockville, Maryland. The two discuss an array of topics from the urgency of greater advocacy participation across the specialty; augmented versus artificial intelligence; the importance of understanding the economics of medicine, including payment and cost containment strategies, and why we should be talking about payment versus reimbursement; balancing life and being involved; 2025 OTO Forum; and more! Helpful Resources: Attend the OTO Forum: https://www.entnet.org/events/aao-hns-f-oto-forum/ Get Involved with OPPS: https://www.entnet.org/get-involved/sections/otolaryngology-private-practice-section/ Note: Contributions to ENT PAC are not deductible as charitable contributions for federal income tax purposes. Contributions are voluntary, and all members of the American Academy of Otolaryngology–Head and Neck Surgery have the right to refuse to contribution without reprisal. Federal law prohibits ENT PAC from accepting contributions from foreign nationals. By law, if your contributions are made using a personal check or credit card, ENT PAC may use your contribution only to support candidates in federal elections. All corporate contributions to ENT PAC will be used for educational and administrative fees of ENT PAC, and other activities permissible under federal law. Federal law requires ENT PAC use its best efforts to collect and report the name, mailing address, occupation, and the name of the employer of individuals whose contributions exceed $200 in a calendar year. ENT PAC is a program of the AAO-HNS which is exempt from federal income tax under section 501 (c) (6) of the Internal Revenue Code.
MB2's Chief Revenue Officer Clint Ellenberg is back for another round to discuss what's happening with insurance right now and how dentists can ensure they're actually getting paid what they deserve. Clint shares what he's seeing across the dental space, from reimbursement challenges to shifting views on in-network participation. We discuss how insurance affects practice profitability, why some dentists are reconsidering their approach, and practical steps to make more informed decisions. ------------------------------------------------------------------------ Subscribe & Listen: Spotify: https://open.spotify.com/show/69Dz26hgC9D6YqwN8JMDBV Apple Podcast: https://podcasts.apple.com/us/podcast/mb2-underground/id1747349567 ---------------------------------------------------------------------- Follow MB2 Dental on Social: MB2 Dental: mb2dental.com Instagram: instagram.com/mb2dental Facebook: facebook.com/mb2dental YouTube: youtube.com/@mb2dental LinkedIn: linkedin.com/mb2-dental
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Kelly Huang, President and CEO of Elucid. Elucid has developed a platform that uses AI to analyze cardiac CT scans to provide a detailed, non-invasive assessment of a patient's arterial plaque. Kelly's journey spans nearly 30 years of leadership in healthcare, with expertise in driving innovation and growth across medical devices, diagnostics, health IT, and consumer health. Before Elucid, he served as COO at Cardea Bio, leading its successful acquisition by Paragraf, and as CEO of Obalon Therapeutics, where he introduced noninvasive medical devices to expand treatment options for physicians. Kelly's career also includes senior roles at L-Nutra, Nestlé/Galderma, Endo Pharmaceuticals, and Johnson & Johnson.In this interview, Kelly shares advice on how to successfully bring novel devices to market, secure reimbursement, and drive adoption by focusing on the essentials—collaboration, trust, robust data, and transparency.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Kelly Huang.
Send us a text You don't have to accept what is given to you. In this episode, Captain Integrity Bob Wade dives into Medicaid reimbursement litigation with Knicole Emanuel, Partner at Nelson Mullins. Hear why litigation is an option to fight low Medicaid rates, why you don't need to accept the reimbursement rates presented, how medical equity works, the David vs. Goliath case Knicole worked on, and some examples in terms of children's dental needs. Learn more at CaptainIntegrity.com
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we had an insightful chat with Nitin Salunke, President and CEO of Supira Medical, a Shifamed portfolio company. Supira is developing a catheter-based heart pump that provides hemodynamic support for patients undergoing high-risk heart procedures. Before Supira, Nitin was Vice President of R&D at Medtronic Neurovascular, overseeing global product development. He has also held leadership roles at Altura Medical, Cordis Corp (then a Johnson & Johnson company), and W.L. Gore & Associates. Nitin holds a PhD in Mechanical Engineering and is an inventor and co-author on many patents and publications.In this interview, Nitin shares the philosophy that guided his journey as CEO of Supira, his strategy to evaluate and address major risk factors in medtech, how to generate value for all stakeholders—patients, physicians, and investors, and his formula for creating a next-gen medical device.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Nitin Salunke.
Send us a textIn this episode of the Advancing Surgical Care Podcast, ASCA Chief Executive Officer Bill Prentice and ASCA Chief Advocacy Officer Kara Newbury preview ASCA's public policy priorities for 2025, including improved Medicare reimbursement for ASCs, additions to the ASC Covered Procedures List (ASC-CPL) and removal of several ASC Quality Reporting Program measures. During their discussion, Prentice and Newbury talk in detail about positively positioning ASCs for the current national political environment, where overall health spending reductions and regulatory reform are already taking precedence in the new Congress and administration.
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Mike Dineen, co-founder and CEO of Tioga Cardiovascular, a Shifamed portfolio company. Tioga is developing a minimally invasive transcatheter mitral valve replacement (TMVR) device to address mitral regurgitation (MR) - a condition where blood flows backward into the heart, often causing heart failure.Mike has 30 years of experience in leading and scaling innovative medical device startups, and is co-inventor on more than 65 patents. His track record encompasses leadership roles at Kalila Medical (acquired by Abbott and later divested to Terumo), Maya Medical (acquired by Covidien), and Aspire Medical (acquired by Philips/Respironics). In this interview, Mike discusses why engaging with physicians early is essential and what he prioritizes in those conversations, the importance of pushing for early pre-clinical testing and how to best approach it, and his strategy for raising capital by targeting early-stage investors with a clear, exit-focused plan.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Mike Dineen.
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we sat down with Jennifer Fried, co-founder and CEO of Flow Medical. Her startup is developing an advanced catheter designed to treat pulmonary embolisms.Jennifer started her career as a healthcare venture capitalist and consultant at Bain & Company. Before co-founding Flow Medical, Jennifer was the CEO and co-founder of ExplORer Surgical, a surgical software platform spun out of research at The University of Chicago. Under her leadership, ExplORer grew from an idea to a global product, earning accolades, like being named one of the Top 50 Healthcare Technology CEOs, and partnerships with major medical device companies. Jennifer successfully exited the business in 2021, when it was acquired by GHX.In this interview, Jennifer shares insights on navigating M&As, raising capital, and tips for validating ideas. She explains why engaging early with potential acquirers is key, how challenging your assumptions can save years of effort, and the importance of tailoring your pitch and building lasting investor relationships.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and 3 packages that will help you make use of our database of 750+ life science investors more efficiently for your fundraise and help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VII. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Jennifer Fried.
In this episode, Susan Xu, Principal at WyDus, joins Duane Mancini to unravel the complexities of reimbursement in the digital health landscape. Susan explains how Medtech startups can navigate the system to get paid for their innovations, covering everything from Health IT and wearables to telehealth and AI. Learn about the crucial role of diagnosis and treatment, key codes like RPM, and the importance of clinical data in securing reimbursement. Tune in for expert insights and ensure your digital health venture gets the financial support it deserves.Susan Xu LinkedInDuane Mancini LinkedInProject Medtech LinkedInProject Medtech Website Midwest Showcase Registration
Nishita Pondugula and Dr Louise King joins Ethics Talk to discuss their article, coauthored with Parmida Maghsoudlou and Dr Vardit Ravitsky: “What Does Our Tolerance of Poor Management of Patients' Pain Have to Do With Reimbursement Inequity for Office-Based Gynecologic Procedures?” Recorded December 5, 2024. Read the full article for free at JournalOfEthics.org
Drs. M. Ali Khan and Ajay Kuriyan join host Dr. Jay Sridhar to discuss updates in the retina space, including the FDA approval of photobiomodulation for dry age-related macular degeneration (AMD), OCT and OCTA reimbursement changes, and surgical technology advances. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
Brews and Tiny Teeth, The Unfiltered Pediatric Dentistry Podcast
Whitney Linville is a a pediatric dentist and practice owner from Louisiana. She graduated from residency in Omaha, Nebraska in 2018, before starting her practice from scratch in Youngsville, Louisiana. This episode is awesome because it's the exact vibe I try to chase after for my podcast. We each have a drink and just talk shop about a whole bunch of awesome peds topics, including: - Dealing with snow, hurricanes, and bad weather - The middle age stage of practice ownership - What the pediatric dental scene is like in Louisiana - Medicaid reimbursement in Louisiana - Patchwork ART/ITR glass ionomer fillings that don't hold up - When not to reimplant an avulsed tooth - Whiny tweenagers who don't want you to touch their loose baby teeth.
Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, CEO of inGENEious RX Incorporated Pharmacogenomics Consulting, and Dr. Megan Landsverk, Scientific Director of MolDX® and Chief Science Officer of Palmetto GBA®, discuss how laboratories may overcome the challenges they face earning MolDX® coverage and reimbursement for their clinical pharmacogenomics tests. Specific to coverage determinations, the PGx veterans discuss test design, post-genotype translations, and technical assessments. Specific to reimbursement, the duo discusses evidence-based reporting and complete claim submissions. Also discussed is the importance of labs clearly defining intended use populations for tests and academic partnerships importance when labs develop and validate panels including drug-gene pairs the Clinical Pharmacogenetics Implementation Consortium and the United States Food and Drug Administration does not recognize as clinically utile for managing medications. Dr. Megan Landsverk is a Science Officer for Palmetto GBA, a Medicare Administrative Contractor (MAC) and a Science Director for the Molecular Diagnostic Services (MolDX) program developed to identify and establish coverage and reimbursement for molecular diagnostic services on behalf of Medicare. Dr. Landsverk received her PhD in Biochemistry and Molecular Biology from Baylor College of Medicine and postdoctoral training in Medical Genetics at the University of Washington. She is a board-certified Molecular Geneticist, completing her molecular genetics fellowship at Baylor College of Medicine. She has held multiple academic faculty positions and has numerous publications in the field of genetics. Prior to joining Palmetto, she served as a clinical laboratory director in academic, hospital, and commercial clinical laboratories and has experience in several genetic specialties including rare disease (pediatric and adult), cancer (somatic and inherited), and pharmacogenetics.
An Amazon FBA shipment change, TikTok shop not allowing dropshipping anymore, and Walmart launching an in-home testing program. These and more buzzing news on this week's episode! ► Instagram: instagram.com/serioussellerspodcast ► Free Amazon Seller Chrome Extension: https://h10.me/extension ► Sign Up For Helium 10: https://h10.me/signup (Use SSP10 To Save 10% For Life) ► Learn How To Sell on Amazon: https://h10.me/ft ► Watch The Podcasts On YouTube: youtube.com/@Helium10/videos We're back with another episode of the Weekly Buzz with Helium 10's Senior Brand Evangelist, Shivali Patel. Every week, we cover the latest breaking news in the Amazon, Walmart, and E-commerce space, talk about Helium 10's newest features, and provide a training tip for the week for serious sellers of any level. Amazon FBA Shipment Change https://sellercentral.amazon.com/help/hub/reference/GC3Q44PBK8BXQW3Z TikTok Shop Drops Dropshipping The TikTok outage caused TikTok Shop sales to spike, not sink https://digiday.com/marketing/the-tiktok-outage-caused-tiktok-shop-sales-to-spike-not-sink/ Apple, Google remove TikTok from stores as app halts service in U.S. https://www.cnbc.com/2025/01/18/apple-google-remove-tiktok-from-stores-as-app-halts-service-in-us.html Apple won't return TikTok to the App Store until it's sold to a U.S. buyer https://appleinsider.com/articles/25/01/21/apple-wont-return-tiktok-to-the-app-store-until-its-sold-to-a-us-buyer Walmart will now let suppliers test products in its customers' homes https://www.modernretail.co/operations/walmart-will-now-let-suppliers-test-products-in-its-customers-homes/ Inventory Defect and Reimbursement portal now available https://sellercentral.amazon.com/seller-news/articles/QVRWUERLSUtYMERFUiNHRkVaMk1ZR05KWFNDSEw2 New Features for Amazon Advertisers https://advertising.amazon.com/API/docs/en-us/release-notes/index New Amazon product title requirements effective January 21, 2025 https://sellercentral.amazon.com/seller-news/articles/QVRWUERLSUtYMERFUiNHNEJGOUZIUUs4SFBXWkRV In the next segment, we turn our attention to exciting new Helium 10 product features and updates in the Amazon marketplace. We introduce powerful features inside Helium 10 Adtomic like the Share of Voice tool. This tool is designed to enhance brand visibility and streamline advertising campaigns. Furthermore, Shivali guides us through a compelling strategy for expanding product offerings by leveraging niche book topics by using Helium 10's Black Box tool for KDP allowing sellers to tap into new markets and diversify income streams. By identifying high-potential keywords with low competition, sellers can capitalize on existing skills and broaden their market presence. Don't miss this episode for a comprehensive look at these critical updates and strategies to enhance your e-commerce success. In this episode of the Weekly Buzz by Helium 10, Bradley covers: 00:47 - Amazon FBA Shipment Change 02:34 - TikTok Shop Drops Dropshipping 04:23 - TikTok Sales Spike 05:36 - TikTok App Unavailable 07:06 - Walmart's Scintilla 08:59 - IDR Portal LIVE 10:33 - New Features for Advertisers 12:06 - Title Policy Reminder 12:51 - Helium 10 New Feature Alerts 19:09 - Training Tip: Black Box For KDP